We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTCF
2351
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $585K | ﹤0.01% |
46,485
-52
| -0.1% | -$658 |
|
2352
Mission Produce
AVO
$1.15B
| $584K | ﹤0.01% |
46,166
+951
| +2% | +$12.7K |
|
2353
Karyopharm Therapeutics
KPTI
$44.4M
| $583K | ﹤0.01% |
5,275
-1,039
| -16% | -$129K |
|
2354
Relmada Therapeutics
RLMD
$515M
| $582K | ﹤0.01% |
21,559
+5,975
| +38% | +$124K |
|
|
GHL
2355
DELISTED
Greenhill & Co., Inc.
GHL
| $580K | ﹤0.01% |
37,460
-429
| -1% | -$7.52K |
|
2356
Bar Harbor Bankshares
BHB
$659M
| $579K | ﹤0.01% |
20,247
-1,840
| -8% | -$54.8K |
|
2357
Heron Therapeutics
HRTX
$71M
| $579K | ﹤0.01% |
101,284
-1,814
| -2% | -$13.3K |
|
2358
PMV Pharmaceuticals
PMVP
$64M
| $577K | ﹤0.01% |
27,690
+1,983
| +8% | +$35K |
|
2359
i3 Verticals
IIIV
$329M
| $576K | ﹤0.01% |
20,658
+2,325
| +13% | +$57.3K |
|
|
BVH
2360
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $573K | ﹤0.01% |
19,389
-2,966
| -13% | -$89.8K |
|
2361
West Bancorporation
WTBA
$483M
| $571K | ﹤0.01% |
20,992
-1,566
| -7% | -$46.3K |
|
2362
MiMedx Group
MDXG
$619M
| $567K | ﹤0.01% |
120,353
+6,250
| +5% | +$30.6K |
|
2363
Old Second Bancorp
OSBC
$1.29B
| $567K | ﹤0.01% |
39,105
-3,556
| -8% | -$49.8K |
|
2364
Clarus
CLAR
$146M
| $566K | ﹤0.01% |
24,852
+185
| +0.7% | +$4.29K |
|
2365
NRC Health Common Stock
NRC
$451M
| $566K | ﹤0.01% |
14,285
+27
| +0.2% | +$1.06K |
|
|
REVG
2366
DELISTED
REV Group
REVG
| $565K | ﹤0.01% |
42,200
+169
| +0.4% | +$2.31K |
|
|
TPIC
2367
DELISTED
TPI Composites
TPIC
| $565K | ﹤0.01% |
40,171
+1,275
| +3% | +$16.3K |
|
|
AD
2368
Array Digital Infrastructure
AD
$3.05B
| $565K | ﹤0.01% |
18,685
-1,383
| -7% | -$41.8K |
|
|
AEVA
2369
Aeva Technologies
AEVA
$1.67B
| $564K | ﹤0.01% |
26,073
+130
| +0.5% | +$3.19K |
|
2370
Veritone
VERI
$133M
| $564K | ﹤0.01% |
30,876
+1,543
| +5% | +$26.6K |
|
|
HCCI
2371
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $563K | ﹤0.01% |
19,028
-1,110
| -6% | -$32.3K |
|
2372
Oppenheimer Holdings
OPY
$1.2B
| $561K | ﹤0.01% |
12,881
-1,142
| -8% | -$50.1K |
|
2373
MacroGenics
MGNX
$259M
| $560K | ﹤0.01% |
63,585
-573
| -0.9% | -$6.33K |
|
2374
Vera Bradley
VRA
$98.1M
| $560K | ﹤0.01% |
72,976
-2,004
| -3% | -$15.8K |
|
|
VRAY
2375
DELISTED
ViewRay, Inc.
VRAY
| $560K | ﹤0.01% |
142,869
+11,203
| +9% | +$47.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.